BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghosh A, Gupta R, Misra A. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr 2020;14:273-6. [PMID: 32283497 DOI: 10.1016/j.dsx.2020.04.001] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 43.5] [Reference Citation Analysis]
Number Citing Articles
1 Anjum MR, Chalmers J, Hamid R, Rajoriya N. COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future. World J Gastroenterol 2021; 27(44): 7625-7648 [PMID: 34908803 DOI: 10.3748/wjg.v27.i44.7625] [Reference Citation Analysis]
2 Misra A. Majorly Resurgent and Uncontrolled Diabetes During COVID19 Era, and in the Future Can Be Contained in India. Diabetes Metab Syndr 2021;15:102142. [PMID: 34045152 DOI: 10.1016/j.dsx.2021.05.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Iyengar K, Jain VK, Vaishya R. Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them. Diabetes Metab Syndr 2020;14:797-9. [PMID: 32534432 DOI: 10.1016/j.dsx.2020.06.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
4 Cheong JL, Goh ZHK, Marras C, Tanner CM, Kasten M, Noyce AJ; Movement Disorders Society Epidemiology Study Group. The Impact of COVID-19 on Access to Parkinson's Disease Medication. Mov Disord 2020;35:2129-33. [PMID: 32860226 DOI: 10.1002/mds.28293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yildiz F, Oksuzoglu B. Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors? Future Oncol 2020;16:2191-5. [PMID: 32857603 DOI: 10.2217/fon-2020-0714] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
6 Mader JK. Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now. J Diabetes Sci Technol 2020;14:752-3. [PMID: 32443942 DOI: 10.1177/1932296820930289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Barone MTU, Ngongo B, Harnik SB, Oliveira LX, Végh D, de Luca PV, Pedrosa HC, Giraudo F, Cardona-Hernandez R, Chaudhury N, Menna-Barreto L. COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis. Diabetes Res Clin Pract 2021;171:108587. [PMID: 33307134 DOI: 10.1016/j.diabres.2020.108587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Iyengar K, Mabrouk A, Jain VK, Venkatesan A, Vaishya R. Learning opportunities from COVID-19 and future effects on health care system. Diabetes Metab Syndr 2020;14:943-6. [PMID: 32599533 DOI: 10.1016/j.dsx.2020.06.036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 18.5] [Reference Citation Analysis]
9 Intawong K, Olson D, Chariyalertsak S. Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand. Biochem Biophys Res Commun 2021;534:830-6. [PMID: 33250175 DOI: 10.1016/j.bbrc.2020.10.097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
10 Denkboy Ongen Y, Eren E, Sahin KC, Buhur Pirimoglu M, Saglam H, Tarim O. Telemedicine experiences at a pediatric endocrinology clinic during the COVID-19 pandemic. Ir J Med Sci 2021. [PMID: 34100191 DOI: 10.1007/s11845-021-02677-1] [Reference Citation Analysis]
11 Elmajnoun HK, Faris ME, Uday S, Gorman S, Greening JE, Haris PI, Abu-Median AB. Impact of COVID-19 on Children and Young Adults With Type 2 Diabetes: A Narrative Review With Emphasis on the Potential of Intermittent Fasting as a Preventive Strategy. Front Nutr 2021;8:756413. [PMID: 34778345 DOI: 10.3389/fnut.2021.756413] [Reference Citation Analysis]
12 Gupta R, Misra A. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India. Diabetes Metab Syndr 2020;14:1777-81. [PMID: 32942253 DOI: 10.1016/j.dsx.2020.09.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Purnamayanti NKD, Wicaksana AL. Digital Health Services among Patients with Diabetes during the COVID-19 Pandemic: A Scoping Review. Indian J Endocrinol Metab 2021;25:86-92. [PMID: 34660235 DOI: 10.4103/ijem.ijem_153_21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14:535-545. [PMID: 32408118 DOI: 10.1016/j.dsx.2020.04.044] [Cited by in Crossref: 164] [Cited by in F6Publishing: 148] [Article Influence: 82.0] [Reference Citation Analysis]
15 Fraticelli F, Nicola MD, Vitacolonna E. A nutritional web-based approach in obesity and diabetes before and during COVID-19 lockdown. J Telemed Telecare 2020;:1357633X20966933. [PMID: 33081596 DOI: 10.1177/1357633X20966933] [Reference Citation Analysis]
16 Lui DTW, Lee CH, Chow WS, Fong CHY, Woo YC, Lam KSL, Tan KCB. A territory-wide study on the impact of COVID-19 on diabetes-related acute care. J Diabetes Investig 2020;11:1303-6. [PMID: 32779868 DOI: 10.1111/jdi.13368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Intawong K, Olson D, Chariyalertsak S. Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand. Biochem Biophys Res Commun 2021;538:231-7. [PMID: 33589143 DOI: 10.1016/j.bbrc.2021.01.093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Singh RP, Javaid M, Kataria R, Tyagi M, Haleem A, Suman R. Significant applications of virtual reality for COVID-19 pandemic. Diabetes Metab Syndr 2020;14:661-4. [PMID: 32438329 DOI: 10.1016/j.dsx.2020.05.011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 33] [Article Influence: 37.0] [Reference Citation Analysis]
19 Shah K, Tiwaskar M, Chawla P, Kale M, Deshmane R, Sowani A. Hypoglycemia at the time of Covid-19 pandemic. Diabetes Metab Syndr 2020;14:1143-6. [PMID: 32668399 DOI: 10.1016/j.dsx.2020.07.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Kesavadev J, Krishnan G, Mohan V. Digital health and diabetes: experience from India. Ther Adv Endocrinol Metab 2021;12:20420188211054676. [PMID: 34820114 DOI: 10.1177/20420188211054676] [Reference Citation Analysis]
21 Khader MA, Jabeen T, Namoju R. A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India. Diabetes Metab Syndr 2020;14:1579-84. [PMID: 32858476 DOI: 10.1016/j.dsx.2020.08.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
22 Parise M, Tartaglione L, Cutruzzolà A, Maiorino MI, Esposito K, Pitocco D, Gnasso A, Irace C. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study. J Med Internet Res 2021;23:e24552. [PMID: 33769945 DOI: 10.2196/24552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zhou L, Seesaghur HN, Akhtar N, Boolakee J, Pratt CB. A Citywide 'Virus Testing': Chinese Government's Response to Preventing and Controlling the Second Outbreak of SARS-CoV-2. Front Public Health 2021;9:601592. [PMID: 34222164 DOI: 10.3389/fpubh.2021.601592] [Reference Citation Analysis]
24 Lim MA, Huang I, Yonas E, Vania R, Pranata R. A wave of non-communicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr 2020;14:979-80. [PMID: 32610263 DOI: 10.1016/j.dsx.2020.06.050] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
25 Nassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, Nyein A, Mohamed M, Alqassieh A, Soliman K, Alfishawy M, Sachmechi I, Misra A. Diabetes Mellitus and COVID-19: Review Article. Diabetes Metab Syndr 2021;15:102268. [PMID: 34562865 DOI: 10.1016/j.dsx.2021.102268] [Reference Citation Analysis]
26 Mishra M, Bano T, Mishra SK, Wasir JS, Kohli C, Kalra S, Choudhary P, Kuchay MS. Effectiveness of diabetes education including insulin injection technique and dose adjustment through telemedicine in hospitalized patients with COVID-19. Diabetes Metab Syndr 2021;15:102174. [PMID: 34186369 DOI: 10.1016/j.dsx.2021.06.011] [Reference Citation Analysis]
27 Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr 2020;14:917-20. [PMID: 32574982 DOI: 10.1016/j.dsx.2020.05.044] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 35.0] [Reference Citation Analysis]
28 Dube T, Ncube SB, Mlotshwa S, Matsika GN, Maonde N. The changing face of monitoring and evaluation in the age of COVID-19: practitioners' field experiences from Zimbabwe. Heliyon 2021;7:e07386. [PMID: 34189334 DOI: 10.1016/j.heliyon.2021.e07386] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gupta R, Hussain A, Misra A. Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur J Clin Nutr. 2020;74:864-870. [PMID: 32404898 DOI: 10.1038/s41430-020-0652-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 33.5] [Reference Citation Analysis]
30 Bahl S, Singh RP, Javaid M, Khan IH, Vaishya R, Suman R. Telemedicine Technologies for Confronting COVID-19 Pandemic: A Review. J Ind Intg Mgmt 2020;05:547-61. [DOI: 10.1142/s2424862220300057] [Cited by in Crossref: 26] [Article Influence: 13.0] [Reference Citation Analysis]
31 Bhattacharyya SS, Thakre S. Coronavirus pandemic and economic lockdown; study of strategic initiatives and tactical responses of firms. IJOA 2021;29:1240-68. [DOI: 10.1108/ijoa-05-2020-2198] [Cited by in Crossref: 12] [Article Influence: 12.0] [Reference Citation Analysis]
32 Alharthi SK, Alyusuf EY, Alguwaihes AM, Alfadda A, Al-Sofiani ME. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia. Diabetes Res Clin Pract 2021;173:108682. [PMID: 33539868 DOI: 10.1016/j.diabres.2021.108682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
33 Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Diabetes Metab Syndr 2020;14:1109-20. [PMID: 32659694 DOI: 10.1016/j.dsx.2020.06.070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
34 Jabarulla MY, Lee HN. A Blockchain and Artificial Intelligence-Based, Patient-Centric Healthcare System for Combating the COVID-19 Pandemic: Opportunities and Applications. Healthcare (Basel) 2021;9:1019. [PMID: 34442156 DOI: 10.3390/healthcare9081019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Misra A, Bloomgarden Z. Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control. J Diabetes 2020;12:556-7. [PMID: 32419360 DOI: 10.1111/1753-0407.13048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
36 Sen IK, Chakraborty I, Mandal AK, Bhanja SK, Patra S, Maity P. A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients. Int J Biol Macromol 2021;181:462-70. [PMID: 33794238 DOI: 10.1016/j.ijbiomac.2021.03.162] [Reference Citation Analysis]
37 Licchetta L, Trivisano M, Baldin E, Mohamed S, Raschi E, Mostacci B, Zenesini C, Contin M, Vigevano F, Bisulli F, Tinuper P, Vignatelli L. TELEmedicine for EPIlepsy Care (TELE-EPIC): protocol of a randomised, open controlled non-inferiority clinical trial. BMJ Open 2021;11:e053980. [PMID: 34862297 DOI: 10.1136/bmjopen-2021-053980] [Reference Citation Analysis]
38 Caballero AE, Ceriello A, Misra A, Aschner P, McDonnell ME, Hassanein M, Ji L, Mbanya JC, Fonseca VA. COVID-19 in people living with diabetes: An international consensus. J Diabetes Complications 2020;34:107671. [PMID: 32651031 DOI: 10.1016/j.jdiacomp.2020.107671] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
39 Kshanti IA, Epriliawati M, Mokoagow MI, Nasarudin J, Magfira N. The Impact of COVID-19 Lockdown on Diabetes Complication and Diabetes Management in People With Diabetes in Indonesia. J Prim Care Community Health 2021;12:21501327211044888. [PMID: 34541963 DOI: 10.1177/21501327211044888] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Singh RP, Javaid M, Haleem A, Suman R. Internet of things (IoT) applications to fight against COVID-19 pandemic. Diabetes Metab Syndr 2020;14:521-4. [PMID: 32388333 DOI: 10.1016/j.dsx.2020.04.041] [Cited by in Crossref: 142] [Cited by in F6Publishing: 55] [Article Influence: 71.0] [Reference Citation Analysis]
41 Joshi R, Atal S, Fatima Z, Balakrishnan S, Sharma S, Joshi A. Diabetes care during COVID-19 lockdown at a tertiary care centre in India. Diabetes Res Clin Pract 2020;166:108316. [PMID: 32673697 DOI: 10.1016/j.diabres.2020.108316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
42 Priya G, Bajaj S, Grewal E, Maisnam I, Chandrasekharan S, Selvan C. Challenges in Women with Diabetes During the COVID-19 Pandemic. Eur Endocrinol 2020;16:100-8. [PMID: 33117440 DOI: 10.17925/EE.2020.16.2.100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Ugliara Barone MT, Harnik SB, Chaluppe M, Vieira de Luca P, Ngongo B, Pedrosa HC, Pirolo V, Franco DR, Malta DC, Giampaoli V. Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes. Diabetes Metab Syndr 2020;14:1973-8. [PMID: 33075740 DOI: 10.1016/j.dsx.2020.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Magliah SF, Alsabban AS, Turkistani HA, Abulaban BA, Alsharif AH, Alsharif SS, Zarif HA. Perception of virtual clinics among Saudi adults with type 1 diabetes during the COVID-19 pandemic. Diabetes Metab Syndr 2021;15:102175. [PMID: 34186374 DOI: 10.1016/j.dsx.2021.06.012] [Reference Citation Analysis]
45 Pareek P, Vishnoi JR, Kombathula SH, Vyas RK, Misra S. Teleoncology: The Youngest Pillar of Oncology. JCO Glob Oncol 2020;6:1455-60. [PMID: 32997540 DOI: 10.1200/GO.20.00295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
46 Das AK, Kalra S, B K, Sharma K, John M, Nair T, Shaikh S, Khandelwal D, Priya G, Dutta D, Gangadhar P, Dhingra A, Tiwaskar M, Shukla R, Das S, Baruah MP, Gangopadhyay KK, Ramakrishnan S, Deshmukh V, Dasgupta A, Kumar G, Pandey N, Joshi A, Surana VK, Punyani H, Shah P, Rattan A, Chandrasekaran S, Asirwatham A. Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion. Diabetes Metab Syndr 2021;15:55-62. [PMID: 33310177 DOI: 10.1016/j.dsx.2020.11.014] [Reference Citation Analysis]
47 Robiony M, Bocin E, Sembronio S, Costa F, Bresadola V, Tel A. Redesigning the Paradigms of Clinical Practice for Oral and Maxillofacial Surgery in the Era of Lockdown for COVID-19: From Tradition to Telesemeiology. Int J Environ Res Public Health 2020;17:E6622. [PMID: 32932911 DOI: 10.3390/ijerph17186622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Magliah SF, Zarif HA, Althubaiti A, Sabban MF. Managing Type 1 Diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown. Diabetes Metab Syndr 2021;15:63-8. [PMID: 33310178 DOI: 10.1016/j.dsx.2020.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Iyengar K, Upadhyaya GK, Vaishya R, Jain V. COVID-19 and applications of smartphone technology in the current pandemic. Diabetes Metab Syndr. 2020;14:733-737. [PMID: 32497963 DOI: 10.1016/j.dsx.2020.05.033] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 24.5] [Reference Citation Analysis]
50 Chatterjee S, Ghosh R, Biswas P, Dubey S, Guria RT, Sharma CB, Kalra S. COVID-19: the endocrine opportunity in a pandemic. Minerva Endocrinol 2020;45:204-27. [PMID: 32548995 DOI: 10.23736/S0391-1977.20.03216-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
51 Jain VK, Iyengar KP, Samy DA, Vaishya R. Tuberculosis in the era of COVID-19 in India. Diabetes Metab Syndr 2020;14:1439-43. [PMID: 32755848 DOI: 10.1016/j.dsx.2020.07.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
52 Pal R, Bhadada SK. Managing common endocrine disorders amid COVID-19 pandemic. Diabetes Metab Syndr 2020;14:767-71. [PMID: 32521463 DOI: 10.1016/j.dsx.2020.05.050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
53 Alvarez-Risco A, Del-Aguila-Arcentales S, Yáñez JA. Telemedicine in Peru as a Result of the COVID-19 Pandemic: Perspective from a Country with Limited Internet Access. Am J Trop Med Hyg 2021:tpmd210255. [PMID: 33999847 DOI: 10.4269/ajtmh.21-0255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
54 Garfan S, Alamoodi AH, Zaidan BB, Al-Zobbi M, Hamid RA, Alwan JK, Ahmaro IYY, Khalid ET, Jumaah FM, Albahri OS, Zaidan AA, Albahri AS, Al-Qaysi ZT, Ahmed MA, Shuwandy ML, Salih MM, Zughoul O, Mohammed KI, Momani F. Telehealth utilization during the Covid-19 pandemic: A systematic review. Comput Biol Med 2021;138:104878. [PMID: 34592585 DOI: 10.1016/j.compbiomed.2021.104878] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Elbarbary NS, Dos Santos TJ, de Beaufort C, Agwu JC, Calliari LE, Scaramuzza AE. COVID-19 outbreak and pediatric diabetes: Perceptions of health care professionals worldwide. Pediatr Diabetes 2020;21:1083-92. [PMID: 32686287 DOI: 10.1111/pedi.13084] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
56 Garg S, Norman GJ. Impact of COVID-19 on Health Economics and Technology of Diabetes Care: Use Cases of Real-Time Continuous Glucose Monitoring to Transform Health Care During a Global Pandemic. Diabetes Technol Ther 2021;23:S15-20. [PMID: 33449822 DOI: 10.1089/dia.2020.0656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14:513-517. [PMID: 32388331 DOI: 10.1016/j.dsx.2020.04.049] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 39.5] [Reference Citation Analysis]
58 Mamun MMA, Khan MR. COVID-19 Delta Variant-of-Concern: A Real Concern for Pregnant Women With Gestational Diabetes Mellitus. Front Endocrinol (Lausanne) 2021;12:778911. [PMID: 34867825 DOI: 10.3389/fendo.2021.778911] [Reference Citation Analysis]
59 Sayed S. COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine. Prim Care Diabetes 2021;15:4-9. [PMID: 32912711 DOI: 10.1016/j.pcd.2020.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Gupta Y, Goyal A, Kubihal S, Golla KK, Tandon N. A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India. Diabetes Metab Syndr 2021;15:407-13. [PMID: 33581594 DOI: 10.1016/j.dsx.2021.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
61 Iftinan GN, Wathoni N, Lestari K. Telepharmacy: A Potential Alternative Approach for Diabetic Patients During the COVID-19 Pandemic. J Multidiscip Healthc 2021;14:2261-73. [PMID: 34447253 DOI: 10.2147/JMDH.S325645] [Reference Citation Analysis]
62 Atri A, Kocherlakota CM, Dasgupta R. Managing diabetic foot in times of COVID-19: time to put the best 'foot' forward. Int J Diabetes Dev Ctries 2020;:1-8. [PMID: 32904959 DOI: 10.1007/s13410-020-00866-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Vaishya R, Bahl S, Singh RP. Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr 2020;14:687-8. [PMID: 32442918 DOI: 10.1016/j.dsx.2020.05.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
64 M Tourkmani A, J ALHarbi T, Rsheed AMB, Alrasheedy AA, ALMadani W, ALJuraisi F, AlOtaibi AF, AlHarbi M, AlAbood AF, Alshaikh AA. The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications. J Telemed Telecare 2021;:1357633X20985763. [PMID: 33525952 DOI: 10.1177/1357633X20985763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
65 Pal R, Yadav U, Verma A, Bhadada SK. Awareness regarding COVID-19 and problems being faced by young adults with type 1 diabetes mellitus amid nationwide lockdown in India: A qualitative interview study. Prim Care Diabetes 2021;15:10-5. [PMID: 32660907 DOI: 10.1016/j.pcd.2020.07.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
66 Jaly I, Iyengar K, Bahl S, Hughes T, Vaishya R. Redefining diabetic foot disease management service during COVID-19 pandemic. Diabetes Metab Syndr 2020;14:833-8. [PMID: 32540738 DOI: 10.1016/j.dsx.2020.06.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
67 Ghosh A, Dutta K, Tyagi K, Gupta R, Misra A. Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic. Diabetes Metab Syndr 2020;14:577-8. [PMID: 32416526 DOI: 10.1016/j.dsx.2020.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
68 Wu ZH, Tang Y, Cheng Q. Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetol 2021;58:139-44. [PMID: 32583078 DOI: 10.1007/s00592-020-01546-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
69 Eberle C, Stichling S. Telemedical Approaches to Managing Gestational Diabetes Mellitus During COVID-19: Systematic Review. JMIR Pediatr Parent 2021;4:e28630. [PMID: 34081604 DOI: 10.2196/28630] [Reference Citation Analysis]
70 Picardo E, Baù MG, Anatrone C, Mondino A, Surace A, Gallo F, Danese S, Mitidieri M. Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers. Int J Gynaecol Obstet 2021. [PMID: 34258764 DOI: 10.1002/ijgo.13825] [Reference Citation Analysis]
71 Qureshi AZ, Ullah S, Aldajani AA, Basson P, AlHabter AM, Ali T, Almubark BM, AlAtwi M, AlIbrahim F, Alsuhaibani A, Al Jadid MS. Telerehabilitation Guidelines in Saudi Arabia. Telemed J E Health 2021;27:1087-98. [PMID: 33497308 DOI: 10.1089/tmj.2020.0355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Kesavadev J, Basanth A, Krishnan G, Vitale R, Parameswaran H, Shijin S, R S, Raj S, Ashik A, Shankar A, Badarudeen S, Raveendran AV, Rajalakshmy I, Sanal G, Manoj A, Jose R, Unes Y, Jothydev S. A new interventional home care model for COVID management: Virtual Covid IP. Diabetes Metab Syndr 2021;15:102228. [PMID: 34330071 DOI: 10.1016/j.dsx.2021.102228] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Yang S, Yu W, Jia P. Telemedicine: A promising approach for diabetes management - Where is the evidence. J Diabetes Complications 2021;35:107802. [PMID: 33308895 DOI: 10.1016/j.jdiacomp.2020.107802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Makkar A, Milsten J, McCoy M, Szyld EG, Lapadula MC, Ganguly A, DeShea LA, Ponniah U. Tele-Echocardiography for Congenital Heart Disease Screening in a Level II Neonatal Intensive Care Unit with Hybrid Telemedicine System. Telemed J E Health 2021. [PMID: 33449839 DOI: 10.1089/tmj.2020.0440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Alonso SG, Marques G, Barrachina I, Garcia-Zapirain B, Arambarri J, Salvador JC, de la Torre Díez I. Telemedicine and e-Health research solutions in literature for combatting COVID-19: a systematic review. Health Technol (Berl) 2021;:1-10. [PMID: 33558838 DOI: 10.1007/s12553-021-00529-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
76 Al-Sofiani ME, Alyusuf EY, Alharthi S, Alguwaihes AM, Al-Khalifah R, Alfadda A. Rapid Implementation of a Diabetes Telemedicine Clinic During the Coronavirus Disease 2019 Outbreak: Our Protocol, Experience, and Satisfaction Reports in Saudi Arabia. J Diabetes Sci Technol 2021;15:329-38. [PMID: 32762362 DOI: 10.1177/1932296820947094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
77 Elvira Arcellana A, Jimeno C. Challenges and Opportunities for Diabetes Care in the Philippines in the Time of the COVID-19 Pandemic. J ASEAN Fed Endocr Soc 2020;35:55-7. [PMID: 33442171 DOI: 10.15605/jafes.035.01.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Moradi F, Ghadiri-Anari A, Enjezab B. COVID-19 and self-care strategies for women with gestational diabetes mellitus. Diabetes Metab Syndr 2020;14:1535-9. [PMID: 32947751 DOI: 10.1016/j.dsx.2020.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
79 El Asnaoui K, Chawki Y. Using X-ray images and deep learning for automated detection of coronavirus disease. J Biomol Struct Dyn 2021;39:3615-26. [PMID: 32397844 DOI: 10.1080/07391102.2020.1767212] [Cited by in Crossref: 66] [Cited by in F6Publishing: 39] [Article Influence: 33.0] [Reference Citation Analysis]
80 Kaminska H, Szarpak L, Kosior D, Wieczorek W, Szarpak A, Al-Jeabory M, Gawel W, Gasecka A, Jaguszewski MJ, Jarosz-Chobot P. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis. Acta Diabetol 2021;58:1101-10. [PMID: 33778910 DOI: 10.1007/s00592-021-01701-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
81 Hassan TA, Sáenz JE, Ducinskiene D, Cook JP, Imperato JS, Zou KH. New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review. J Multidiscip Healthc 2021;14:2453-65. [PMID: 34522102 DOI: 10.2147/JMDH.S313626] [Reference Citation Analysis]